• AAPL 189.43
  • TSLA 235.58
  • AMZN 144.84
  • BTC-USD 41610.9414
  • ETH-USD 2202.1445
  • EURUSD 1.0833
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. SNY.US

Sanofi ADR (SNY NASDAQ) stock market data APIs

$46.75 -0.27(-0.6%) as of December 4, 2023

Sanofi ADR Financial Data Overview

47.02
46.75
-
47.15
46.6
42.63-55.72
118 609 M
11.9491
2 508 M
45 699 M
2.77
0.0407
0.436
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SNY',
Type: 'Common Stock',
Name: 'Sanofi ADR',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BBD5N1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1121404',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2002-07-01',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Pharmaceuticals',
GicSubIndustry: 'Pharmaceuticals',
HomeCategory: 'ADR Primary',
IsDelisted: false,
}

Sanofi ADR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 45 699 M
  • EBITDA 13 326 M
  • Earnings Per Share 3.93
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Sanofi ADR Earnings via APIs

  • Latest Release 2023-10-26
  • EPS/Forecast 2.27

Get Sanofi ADR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Sanofi ADR latest news via APIs

Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment

PARSIPPANY, N.J., November 30, 2023--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today closing of its collaboration ...

2 Biotech Stocks You Can Buy and Hold for the Next Decade

These stocks aren't popular on the market right now, but investors shouldn't let that scare them off. Continue reading
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com